Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834

Article  PubMed  Google Scholar 

Rawla, P. (2019). Epidemiology of prostate cancer. World Journal of Oncology, 10(2), 63–89. https://doi.org/10.14740/wjon1191

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamdy, F. C., Donovan, J. L., Lane, J. A., Mason, M., Metcalfe, C., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., Oxley, J., Robinson, M., Staffurth, J., Walsh, E., Bollina, P., Catto, J., Doble, A., Doherty, A., Gillatt, D., . . . Neal, D. E. (2016). 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. New England Journal of Medicine, 375(15), 1415–1424. https://doi.org/10.1056/NEJMoa1606220

Neal, D. E., Metcalfe, C., Donovan, J. L., Lane, J. A., Davis, M., Young, G. J., Dutton, S. J., Walsh, E. I., Martin, R. M., Peters, T. J., Turner, E. L., Mason, M., Bryant, R., Bollina, P., Catto, J., Doherty, A., Gillatt, D., Gnanapragasam, V., Holding, P., . . . Hamdy, F. C. (2020). Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protect randomised controlled trial according to treatment received. European Urology, 77(3), 320–330. https://doi.org/10.1016/j.eururo.2019.10.030

Parker, C. C., James, N. D., Brawley, C. D., Clarke, N. W., Hoyle, A. P., Ali, A., Ritchie, A. W. S., Attard, G., Chowdhury, S., Cross, W., Dearnaley, D. P., Gillessen, S., Gilson, C., Jones, R. J., Langley, R. E., Malik, Z. I., Mason, M. D., Matheson, D., Millman, R., . . . Sydes, M. R. (2018). Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet, 392(10162), 2353–2366. https://doi.org/10.1016/s0140-6736(18)32486-3

Zapatero, A., Guerrero, A., Maldonado, X., Alvarez, A., Segundo, C. G., Cabeza Rodríguez, M. A., Macias, V., Pedro Olive, A., Casas, F., Boladeras, A., de Vidales, C. M., Vazquez de Torre, M. L., Villà, S., Perez de la Haza, A., & Calvo, F. A. (2015). High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. The lancet Oncology, 16(3), 320–327. https://doi.org/10.1016/s1470-2045(15)70045-8

Article  CAS  PubMed  Google Scholar 

De Neve, W., De Gersem, W., & Madani, I. (2012). Rational use of intensity-modulated radiation therapy: The importance of clinical outcome. Seminars in Radiation Oncology, 22(1), 40–49. https://doi.org/10.1016/j.semradonc.2011.09.003

Article  PubMed  Google Scholar 

Forsythe, K., Blacksburg, S., Stone, N., & Stock, R. G. (2012). Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer. International Journal of Radiation Oncology Biology Physics, 83(2), 630–635. https://doi.org/10.1016/j.ijrobp.2011.06.2013

Article  PubMed  Google Scholar 

Frank, S. J., Pisters, L. L., Davis, J., Lee, A. K., Bassett, R., & Kuban, D. A. (2007). An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Journal of Urology, 177(6), 2151–2156. https://doi.org/10.1016/j.juro.2007.01.134

Article  PubMed  Google Scholar 

Joly, F., Degrendel, A. C., & Guizard, A. V. (2010). Quality of life after radiotherapy for prostate cancer. Cancer Radiothérapie, 14(6–7), 519–525.

Article  CAS  PubMed  Google Scholar 

Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., Warrington, L., Zhang, L., Apostolidis, K., Freeman-Daily, J., Ripamonti, C. I., & Santini, D. (2022). The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Annals of Oncology, 33(9), 878–892. https://doi.org/10.1016/j.annonc.2022.04.007

Article  PubMed  Google Scholar 

Barbera, L., Sutradhar, R., Seow, H., Mittmann, N., Howell, D., Earle, C. C., Li, Q., & Thiruchelvam, D. (2020). The impact of routine edmonton symptom assessment system (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis. Cancer Medicine, 9(19), 7107–7115. https://doi.org/10.1002/cam4.3374

Article  PubMed  PubMed Central  Google Scholar 

Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology, 34(6), 557–565. https://doi.org/10.1200/jco.2015.63.0830

Article  CAS  PubMed  Google Scholar 

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. C., & Letellier, C. (2019). Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA, 321(3), 306–307. https://doi.org/10.1001/jama.2018.18085

Article  PubMed  PubMed Central  Google Scholar 

Balitsky, A. K., Rayner, D., Britto, J., Lionel, A. C., Ginsberg, L., Cho, W., Wilfred, A. M., Sardar, H., Cantor, N., Mian, H., Levine, M. N., & Guyatt, G. H. (2024). Patient-reported outcome measures in cancer care: An updated systematic review and meta-analysis. JAMA Network Open, 7(8), e2424793. https://doi.org/10.1001/jamanetworkopen.2024.24793

Article  PubMed  PubMed Central  Google Scholar 

Perry, M. B., Taylor, S., Khatoon, B., Vercell, A., Faivre-Finn, C., Velikova, G., Marsden, A., Heal, C., & Yorke, J. (2024). Examining the effectiveness of electronic patient-reported outcomes in people with cancer: Systematic review and meta-analysis. Journal of Medical Internet Research, 26, e49089. https://doi.org/10.2196/49089

Article  PubMed  PubMed Central  Google Scholar 

Anatchkova, M., Donelson, S. M., Skalicky, A. M., McHorney, C. A., Jagun, D., & Whiteley, J. (2018). Exploring the implementation of patient-reported outcome measures in cancer care: Need for more real-world evidence results in the peer reviewed literature. Journal of Patient-Reported Outcomes, 2(1), 64. https://doi.org/10.1186/s41687-018-0091-0

Article  PubMed  PubMed Central  Google Scholar 

Cheung, Y. T., Chan, A., Charalambous, A., Darling, H. S., Eng, L., Grech, L., van den Hurk, C. J. G., Kirk, D., Mitchell, S. A., Poprawski, D., Rammant, E., Ramsey, I., Fitch, M. I., & Chan, R. J. (2022). The use of patient-reported outcomes in routine cancer care: Preliminary insights from a multinational scoping survey of oncology practitioners. Supportive Care in Cancer, 30(2), 1427–1439. https://doi.org/10.1007/s00520-021-06545-7

Article  PubMed  Google Scholar 

Nguyen, H., Butow, P., Dhillon, H., & Sundaresan, P. (2021). A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care. Jouranl of Medical Radiation Sciences, 68(2), 186–195. https://doi.org/10.1002/jmrs.421

Article  Google Scholar 

Layer, K., Layer, J. P., Glasmacher, A. R., Sarria, G. R., Böhner, A. M. C., Layer, Y. L., Dejonckheere, C. S., Garbe, S., Feyer, P., Baumert, B. G., Schendera, A., Baumann, R., Krug, D., Köksal, M. A., Koch, D., Scafa, D., Leitzen, C., Hölzel, M., Giordano, F. A., & Schmeel, L. C. (2023). Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: Results of a multicentric survey among the German-speaking radiation oncology community. Strahlentherapie und Onkologie, 199(10), 891–900. https://doi.org/10.1007/s00066-023-02074-w

Article  PubMed  PubMed Central  Google Scholar 

Sprave, T., Pfaffenlehner, M., Stoian, R., Christofi, E., Rühle, A., Zöller, D., Fabian, A., Fahrner, H., Binder, H., Schäfer, H., Gkika, E., Grosu, A. L., Heinemann, F., & Nicolay, N. H. (2023). App-controlled treatment monitoring and support for patients with head and neck cancer undergoing radiotherapy: Results from a prospective randomized controlled trial. Journal of Medical Internet Research, 25, e46189. https://doi.org/10.2196/46189

Article  PubMed  PubMed Central  Google Scholar 

Tran, C., Dicker, A., Leiby, B., Gressen, E., Williams, N., & Jim, H. (2020). Utilizing digital health to collect electronic patient-reported outcomes in prostate cancer: Single-arm pilot trial. Journal of Medical Internet Research, 22(3), e12689. https://doi.org/10.2196/12689

Article  PubMed  PubMed Central  Google Scholar 

Basch, E., Rocque, G., Mody, G., Mullangi, S., & Patt, D. (2023). Tenets for implementing electronic patient-reported outcomes for remote symptom monitoring during cancer treatment. JCO Clinical Cancer Informatics, 7, e2200187. https://doi.org/10.1200/cci.22.00187

Article  PubMed  Google Scholar 

Henderson, N. L., Basch, E. M., & Rocque, G. B. (2024). Learning to overcome barriers to electronic patient-reported outcome implementation: lessons from the field. JCO Oncology Practice, 20(6), 751–753. https://doi.org/10.1200/op.24.00104

Article  PubMed  Google Scholar 

Janssen, S., El Shafie, R. A., Grohmann, M., Knippen, S., Putora, P. M., Beck, M., Baehr, A., Clemens, P., Stefanowicz, S., Rades, D., Becker, J. N., & Fahlbusch, F. B. (2024). Survey in radiation oncology departments in Germany, Austria, and Switzerland: State of digitalization by 2023. Strahlentherapie und Onkologie, 200(6), 497–506. https://doi.org/10.1007/s00066-023-02182-7

Article  PubMed  Google Scholar 

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Annals of Internal Medicine, 147(8), 573–577. https://doi.org/10.7326/0003-4819-147-8-200710160-00010

Article  Google Scholar 

Holzner, B., Giesinger, J. M., Pinggera, J., Zugal, S., Schöpf, F., Oberguggenberger, A. S., Gamper, E. M., Zabernigg, A., Weber, B., & Rumpold, G. (2012). The computer-based health evaluation software (CHES): A software for electronic patient-reported outcome monitoring. BMC Medical Informatics and Decision Making, 12, 126. https://doi.org/10.1186/1472-6947-12-126

Article  PubMed  PubMed Central  Google Scholar 

MacLennan, S., Williamson, P. R., Bekema, H., Campbell, M., Ramsay, C., N’Dow, J., MacLennan, S., Vale, L., Dahm, P., Mottet, N., & Lam, T. (2017). A core outcome set for localised prostate cancer effectiveness trials. BJU International, 120(5b), E64-e79. https://doi.org/10.1111/bju.13854

Article  PubMed